Orthopedic Biomaterials Market Report 2025

The orthopedic biomaterials market size has grown rapidly in recent years. It will grow from $20.51 billion in 2024 to $22.6 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to advancement in technologies, and rise in healthcare expenditure, growth in the number of healthcare facilities and economic growth.

The orthopedic biomaterials market size is expected to see rapid growth in the next few years. It will grow to $33.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increased prevalence of obesity and arthritis conditions, rapid growth in the geriatric population and increase in joint replacement surgical procedures. Major trends in the forecast period include manufacturing implants using 3d printing technology, developing new innovative products, developing smart biomaterials implants, and on merger and acquisition activities.

The increasing prevalence of musculoskeletal disorders is anticipated to drive the orthopedic biomaterials market. These disorders can lead to fractures, swelling, and discomfort in the joints, ligaments, and tendons, resulting in mobility impairments. The burden of musculoskeletal conditions tends to rise with age. For example, in January 2024, GOV.UK, a UK-based government department, reported that in 2023, 18.4% of individuals aged 16 and older indicated they had a long-term musculoskeletal (MSK) condition, up from 17.6% in 2022. As a result, the incidence of musculoskeletal disorders is expected to significantly influence the growth of the orthopedic biomaterials market.

The growth of the orthopedic biomaterials market is expected to be fueled by the increasing prevalence of knee replacements. Knee replacement, also referred to as knee arthroplasty, involves a surgical procedure to replace a damaged or worn-out knee joint with an artificial joint or prosthesis. The utilization of orthopedic biomaterials in knee replacements has significantly improved outcomes and enhanced the quality of life for patients with knee joint issues, providing the necessary strength, durability, and biocompatibility. For instance, in March 2023, the Centers for Advanced Orthopaedics, a US-based medical center specializing in orthopedic care, reported that the US witnesses 790,000 total knee replacements and 450,000 hip replacements annually. Hence, the increasing prevalence of knee replacements is a key driver of the growth observed in the orthopedic biomaterials market.

The recent advancement of 3D printing technology for orthopedic implants is a notable development in the orthopedic biomaterials market. This technology is employed to manufacture a diverse range of medical equipment, especially those with intricate structures tailored to a patient's specific anatomy. 3D printing of orthopedic implants allows for the creation of more natural anatomical shapes and the design of porous bone replacement scaffolds that seamlessly integrate with the implant, promoting natural bone regeneration for enhanced reliability. This trend has garnered significant attention from various players in the orthopedic biomaterial market, exemplified by Germany-based chemical company Evonik's investment in Chinese 3D printed implant startup Meditool. Meditool utilizes polyether ketone (PEEK) polymer supplied by Evonik in its 3D printing process.

Major companies in the orthopedic biomaterials market are directing their efforts toward innovative products, such as tendon fixation devices, to drive market revenues. Tendon fixation devices are medical instruments or implants used in orthopedic surgery to secure tendons, ligaments, or soft tissues to bone. In June 2023, Acuitive Technologies Inc., a US-based company specializing in innovative orthopedic biomaterial technologies, introduced a novel tendon fixation device. This ACL device features a unique design with a tendon-friendly spiral thread made of citregen, a next-generation resorbable material known for its special molecular and mechanical characteristics. This material technology enhances tendon fixation by contributing to the natural healing process and preventing chronic inflammation, a concern with some other biodegradable devices.

In September 2023, US-based medical technology company Enovis acquired Lima Corporate for $847 million. Enovis anticipates strategic advantages from this acquisition, including opportunities for growth in its successful recon portfolio and an expanded global presence. The acquisition is expected to deliver improved financial results, driven by strong cross-selling revenue growth prospects and significant cost reductions. Lima Corporate, an Italy-based company, specializes in the manufacturing of orthopedic biomaterials.

Major companies operating in the orthopedic biomaterials market include Medtronic PLC, Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Wright Medical Group N.V., Orthofix Medical Inc., Acelity, Conmed Corporation, Aesculap, Seaspine Holdings Corporation, Bone Support AB, Bioventus, K2M Group Holdings, Inc., MTF Biologics, Amedica Corporation, TPL Biomed, Fidia Farmaceutici S.p.A., OsteoRemedies, Xtant Medical, RTI Surgical Holdings, Inc., LifeNet Health, VIVEX Biologics, DJO Global, MedShape, Evonik Industries AG, Heraeus Medical, 3M Company, Collagen Solutions plc.

North America was the largest region in the orthopedic biomaterials market in 2024. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Orthopedic biomaterials refer to materials designed to be integrated into the human body as components of devices aimed at performing specific biological functions, either by substituting or repairing various tissues, including bones, cartilage, ligaments, tendons, and others.

This report on the orthopedic biomaterials market divides the industry into segments based on material type, encompassing ceramics and bioactive glasses, calcium phosphate cement, polymers, metals, and composites. Polymers, a category of orthopedic biomaterials, are intended for insertion into the human body to fulfill specific functions. The applications of orthopedic biomaterials include orthopedic implants, joint replacement/reconstruction, bio-resorbable tissue fixation, orthobiologics, and viscosupplementation. These materials find use across various end-users, including hospitals, clinics, and others.

The orthopedic biomaterials market research report is one of a series of new reports that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with an orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. The orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.